Decreased Susceptibility to Cefepime in a Clinical Strain ofEscherichia coliRelated to Plasmid- and Integron-Encoded OXA-30 β-Lactamase
Open Access
- 1 July 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (7) , 2380-2381
- https://doi.org/10.1128/aac.47.7.2380-2381.2003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic SupportCurrent Pharmaceutical Biotechnology, 2002
- Integron-Locatedoxa-32Gene Cassette Encoding an Extended-Spectrum Variant of OXA-2 β-Lactamase fromPseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2002
- Oxacillinase-Mediated Resistance to Cefepime and Susceptibility to Ceftazidime inPseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2001
- β-Lactamases in Shigella flexneri Isolates from Hong Kong and Shanghai and a Novel OXA-1-Like β-Lactamase, OXA-30Antimicrobial Agents and Chemotherapy, 2000
- OXA-type beta-lactamases.1999
- Detection of OXA-4 beta-lactamase in Pseudomonas aeruginosa isolates by genetic methods.Journal of Antimicrobial Chemotherapy, 1999
- Extended-spectrum beta-lactamases in Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1998
- Trends in β‐Lactam Resistance Among EnterobacteriaceaeClinical Infectious Diseases, 1998
- Gene cassettes: a new class of mobile elementMicrobiology, 1995
- Precise insertion of antibiotic resistance determinants into Tn21-like transposons: nucleotide sequence of the OXA-1 beta-lactamase gene.Proceedings of the National Academy of Sciences, 1987